Surveillance imaging ‘unjustified’ in rituximab-treated lymphoma

Surveillance fluorodeoxyglucose positron emission tomography delivers a high false-positive rate and has low specificity during follow up in diffuse large cell lymphoma patients treated with rituximab, a study shows.

via Med Wire News